FIELD: medicine.
SUBSTANCE: blood angiogenic factors sFlt-1 and PIGF are measured in the pregnant women with clinically and laboratory diagnosed placental insufficiency (PI); that is followed by calculating the angiogenic coefficient Ka by formula: Ka=sFlt-1/(PIGF×10), and if Ka makes 250 or more, preeclampsia is predicted in the pregnant woman with PI.
EFFECT: method enables predicting preeclampsia in the pregnant women with PI for the purpose of selecting further therapeutic approach on the basis of the determined coefficient; in the end it enables making a decision on the rate and extent of clinical-laboratory examination involving all the measures conducted at a suspicion on preeclampsia.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CHOOSING MANAGEMENT OF PREGNANT WOMEN WITH PLACENTAL INSUFFICIENCY AND FOETAL GROWTH INHIBITION SYNDROME | 2013 |
|
RU2517374C2 |
| METHOD FOR CHOOSING MANAGEMENT APPROACH TO PREGNANT WOMEN WITH MILD ARTERIAL HYPERTENSION | 2011 |
|
RU2477476C1 |
| METHOD FOR CHOOSING MANAGEMENT APPROACH TO PREGNANT WOMEN WITH PLACENTAL INSUFFICIENCY AND FOETAL GROWTH RETARDATION SYNDROME (FGRS) | 2015 |
|
RU2595884C1 |
| METHOD FOR CHOOSING MANAGEMENT APPROACH TO PREGNANT WOMEN WITH MODERATE PREECLAMPSIA | 2011 |
|
RU2477481C1 |
| METHOD FOR PREDICTION OF EARLY PREECLAMPSIA IN THE PERIOD OF 11-13 WEEKS | 2018 |
|
RU2732489C2 |
| METHOD OF EARLY PREDICTION OF PREECLAMPSIA PROGRESSION | 2016 |
|
RU2648872C1 |
| METHOD FOR FORMING RISK GROUP OF PRE-ECLAMPSIA | 2021 |
|
RU2762204C1 |
| METHOD OF PROLONGING PREGNANCY IN EARLY PRE-ECLAMPSIA | 2023 |
|
RU2803574C1 |
| METHOD FOR EARLY PREDICTION OF PLACENTAL INSUFFICIENCY | 2009 |
|
RU2410030C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPMENT OF PRE-ECLAMPSIA IN WOMEN OF DIFFERENT SOMATOTYPES | 2018 |
|
RU2679111C1 |
